• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

百日咳流行病学的变化:旧貌换新颜。

Changing pertussis epidemiology: everything old is new again.

机构信息

Centers for Disease Control and Prevention, Atlanta, Georgia.

出版信息

J Infect Dis. 2014 Apr 1;209(7):978-81. doi: 10.1093/infdis/jiu001.

DOI:10.1093/infdis/jiu001
PMID:24626532
Abstract

Before vaccination, pertussis was a universal disease of early childhood. Although apparent control of the disease in the United States and other countries was achieved through vaccination, pertussis is resurgent. Though acellular vaccines have been in use for 20 years, new data are emerging on their effectiveness and durability of protection and the contribution of these characteristics to the resurgence of pertussis.

摘要

在疫苗接种之前,百日咳是一种普遍发生于幼儿期的疾病。尽管通过疫苗接种在美国和其他国家实现了对该病的明显控制,但百日咳仍在卷土重来。虽然无细胞疫苗已经使用了 20 年,但关于其有效性和保护持久性的新数据以及这些特性对百日咳卷土重来的影响正在不断涌现。

相似文献

1
Changing pertussis epidemiology: everything old is new again.百日咳流行病学的变化:旧貌换新颜。
J Infect Dis. 2014 Apr 1;209(7):978-81. doi: 10.1093/infdis/jiu001.
2
Do we need a new vaccine to control the re-emergence of pertussis?我们是否需要一种新疫苗来控制百日咳的再次出现?
Trends Microbiol. 2014 Feb;22(2):49-52. doi: 10.1016/j.tim.2013.11.007.
3
Possible options for new pertussis vaccines.可能的新型百日咳疫苗选择。
J Infect Dis. 2014 Apr 1;209 Suppl 1:S24-7. doi: 10.1093/infdis/jit531.
4
Pertussis: pertussis control strategies and the options for improving current vaccines.百日咳:百日咳控制策略及改进现有疫苗的选择
Expert Rev Vaccines. 2014 Sep;13(9):1071-2. doi: 10.1586/14760584.2014.944166. Epub 2014 Aug 4.
5
Licensed pertussis vaccines in the United States. History and current state.美国的获许可的百日咳疫苗。历史与现状。
Hum Vaccin Immunother. 2014;10(9):2684-90. doi: 10.4161/hv.29576. Epub 2014 Nov 6.
6
Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge.百日咳死灰复燃:百日咳工作组会议对病因、可能的前进方向及知识空白的观点
J Infect Dis. 2014 Apr 1;209 Suppl 1:S32-5. doi: 10.1093/infdis/jit491.
7
Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations.百日咳疫苗的临床评价:美国食品和药物管理局的监管考虑因素。
J Infect Dis. 2014 Apr 1;209 Suppl 1:S28-31. doi: 10.1093/infdis/jit532.
8
Re-emergence of pertussis: what are the solutions?百日咳再现:有何应对之策?
Expert Rev Vaccines. 2012 Nov;11(11):1331-46. doi: 10.1586/erv.12.118.
9
Development of improved vaccines against whooping cough: current status.百日咳新型疫苗的研发:现状
Hum Vaccin. 2010 Jul;6(7):543-53. doi: 10.4161/hv.6.7.11413. Epub 2010 Jul 1.
10
Whither pertussis?百日咳何去何从?
Expert Rev Anti Infect Ther. 2015 Feb;13(2):145-8. doi: 10.1586/14787210.2015.986462. Epub 2014 Nov 26.

引用本文的文献

1
Evaluating the Relationship Between the Introduction of the Acellular Pertussis Vaccine and Whooping Cough Resurgence in the United States.评估无细胞百日咳疫苗的引入与美国百日咳疫情复发之间的关系。
Vaccines (Basel). 2025 Aug 7;13(8):841. doi: 10.3390/vaccines13080841.
2
Resurgence of Pertussis in the Autonomous Province of Vojvodina, Serbia: Shifting Seasonality, Age Patterns, and the Need for Booster Immunization.塞尔维亚伏伊伏丁那自治省百日咳疫情再现:季节性变化、年龄模式及加强免疫需求
Vaccines (Basel). 2025 Jul 31;13(8):814. doi: 10.3390/vaccines13080814.
3
Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies.
百日咳的再度流行:流行病学趋势、致病机制及预防策略。
Front Immunol. 2025 Jul 10;16:1618883. doi: 10.3389/fimmu.2025.1618883. eCollection 2025.
4
exhibits genomic diversity within patients and laboratory culture.在患者体内和实验室培养环境中呈现出基因组多样性。
mSystems. 2025 Jul 22;10(7):e0171724. doi: 10.1128/msystems.01717-24. Epub 2025 Jun 17.
5
Severe pertussis infections in pediatric intensive care units: a multicenter study.儿科重症监护病房中的重症百日咳感染:一项多中心研究。
Eur J Pediatr. 2025 Jan 15;184(2):138. doi: 10.1007/s00431-025-05978-0.
6
Current Progress in the Development of mRNA Vaccines Against Bacterial Infections.抗细菌感染mRNA疫苗的研发进展
Int J Mol Sci. 2024 Dec 6;25(23):13139. doi: 10.3390/ijms252313139.
7
Mucosal vaccination with outer membrane vesicles derived from reduces nasal bacterial colonization after experimental infection.用源自[具体来源未给出]的外膜囊泡进行黏膜疫苗接种可减少实验性感染后的鼻腔细菌定植。
Front Immunol. 2024 Nov 28;15:1506638. doi: 10.3389/fimmu.2024.1506638. eCollection 2024.
8
Resurgence of Pertussis in the Gyeongnam Region of South Korea in 2023 and 2024.2023年和2024年韩国庆南地区百日咳疫情的再度出现。
Vaccines (Basel). 2024 Nov 8;12(11):1261. doi: 10.3390/vaccines12111261.
9
Pertussis Outbreak During 2023 in Gipuzkoa, North Spain.2023年西班牙北部吉普斯夸省百日咳疫情
Vaccines (Basel). 2024 Oct 18;12(10):1192. doi: 10.3390/vaccines12101192.
10
A whole-cell pertussis vaccine engineered to elicit reduced reactogenicity protects baboons against pertussis challenge.一种经过工程改造以降低反应原性的全细胞百日咳疫苗可保护食蟹猴免受百日咳挑战。
mSphere. 2024 Nov 21;9(11):e0064724. doi: 10.1128/msphere.00647-24. Epub 2024 Oct 23.